ELVN Market Cap & Key Metrics
Enliven Therapeutics, Inc.
$39.28
-$0.21(-0.53%)
36
Overall
60
Value
9
Tech
39
Quality
Market Cap
$2.88B
Volume
1.22M
52W Range
$14.79 - $62.32
Target Price
$72.54
ELVN market cap is $2.88B. This page lists Enliven Therapeutics, Inc.'s P/E ratio, EPS estimates, dividend yield, payout ratio and MarketXLS scores.
ELVN Key Metrics
- Market cap
- $2.88B
- EPS estimate, current year
- $-1.75
- EPS growth, 3-year
- -100.00%
- Value score
- 60
- Quality score
- 39
- Technical score
- 9
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| EBITDA | -$119.67M | -$103.37M | -$71.29M | -$37.45M | -$51.13M |
| EPS | $-1.83 | $-1.89 | $-2.01 | $0.24 | $-9.48 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | ELVN | $39.28 | -0.5% | 1.22M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Enliven Therapeutics, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW